<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Photosensitive disorders: Clinical features</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Photosensitive disorders: Clinical features</h1>
<div class="graphic"><div class="figure"><div class="ttl">Photosensitive disorders: Clinical features</div><div class="cntnt"><table cellspacing="0"><colgroup span="12" width="8%"></colgroup> <tbody> <tr> <td class="subtitle1"> </td> <td class="subtitle1">Sex</td> <td class="subtitle1">Age of onset</td> <td class="subtitle1">Timeline of eruption</td> <td class="subtitle1">Location</td> <td class="subtitle1">Common lesion morphology and symptoms</td> <td class="subtitle1">Family history</td> <td class="subtitle1">Action spectrum</td> <td class="subtitle1">Phototesting</td> <td class="subtitle1">Laboratory findings</td> <td class="subtitle1">Duration/ resolution</td> <td class="subtitle1">Key features</td> </tr> <tr> <td><strong>Polymorphous light eruption</strong></td> <td>F&gt;M</td> <td>First 3 decades</td> <td>Hours after sun exposure, lasts days to weeks; most conspicuous in spring; improves during summer</td> <td>Sun-exposed areas</td> <td>Pruritic papules, papulovesicles, plaques.</td> <td>May be present</td> <td>UVA, UVB, visible</td> <td>Normal MED; provocative phototesting may induce lesions</td> <td> </td> <td>Recurrent over the course of years, may improve over time</td> <td>Most common photodermatosis; "hardening" phenomenon may occur</td> </tr> <tr class="highlight_lght_gray_text"> <td><strong>Juvenile spring eruption</strong></td> <td>M&gt;F</td> <td>Primarily childhood; also may be seen in young adults</td> <td>As with polymorphous light eruption</td> <td>Classically, helices of ears</td> <td>Erythematous papules, bullae.</td> <td>May be present</td> <td>UVA?</td> <td>As with polymorphous light eruption</td> <td> </td> <td>Recurrent over years, may improve with age</td> <td> </td> </tr> <tr> <td><strong>Actinic prurigo</strong></td> <td>F&gt;M, M&gt;F reported in adult onset in Asia</td> <td>Childhood; adult onset may occur in Asians</td> <td>Persistent during summer; may also be present year round</td> <td>Sun-exposed areas, may also affect unexposed areas</td> <td>Pruritic papulonodules, crusts, excoriations, lichenification, cheilitis.</td> <td>Yes, in up to 50%</td> <td>UVA&gt;UVB</td> <td>60% with reduced MED, 60 to 70% with positive provocative phototests</td> <td> </td> <td>Improves in adolescence, but also may persist</td> <td>More common in American Indians and Mestizos. May have ocular findings.</td> </tr> <tr class="highlight_lght_gray_text"> <td><strong>Hydroa vacciniforme</strong></td> <td>Slight M&gt;F</td> <td>Childhood</td> <td>Hours after sun exposure</td> <td>Face, dorsal hands</td> <td>Erythematous macules, papules, vesicles, crusts.</td> <td>Rarely positive</td> <td>Likely UVA</td> <td>May show reduced MED to UVA in some cases</td> <td> </td> <td>Usually resolves by adolescence/young adulthood, but may persist</td> <td>Lymphoproliferative disease association with severe cases</td> </tr> <tr> <td><strong>Chronic actinic dermatitis</strong></td> <td>M&gt;F</td> <td>Older, but may be seen in younger patients</td> <td>Persistent; worsens in summer, may have findings year round</td> <td>Sun-exposed areas</td> <td>Eczematous patches, lichenification, may see palmoplantar involvement.</td> <td> </td> <td>UVA, UVB, visible light</td> <td>Decreased MEDs to UVA, UVB, or visible light</td> <td>May see Sézary cells in severe cases</td> <td>Persists for years, may resolve</td> <td>Often coexistent contact dermatitis</td> </tr> <tr class="highlight_lght_gray_text"> <td><strong>Solar urticaria</strong></td> <td>F&gt;M</td> <td>Young or mid-adulthood</td> <td>Appears within minutes, individual lesions resolve within 24 hours</td> <td>Sun-exposed areas</td> <td>Urticarial plaques (hives), occasional systemic symptoms.</td> <td> </td> <td>UVA, UVB, visible light</td> <td>Evaluated with MUD</td> <td> </td> <td>Persists for years, may resolve</td> <td>"Hardening" phenomenon may occur</td> </tr> <tr> <td><strong>Phototoxicity</strong></td> <td>M = F</td> <td>Any age</td> <td>Appears within hours of sun exposure, can occur after first dose of drug</td> <td>Sun-exposed areas</td> <td>Exacerbated sunburn appearance.</td> <td> </td> <td>UVA</td> <td>In systemic phototoxicity, MED for UVA decreased, UVB and visible light MEDs normal</td> <td> </td> <td>Resolves when drug discontinued and cleared from body</td> <td>Can occur in anyone</td> </tr> <tr class="highlight_lght_gray_text"> <td><strong>Photoallergy</strong></td> <td>M = F</td> <td>Any age</td> <td>Appears 1 to 2 days after exposure to sun and inciting agent in sensitized individual</td> <td>Sun-exposed areas</td> <td>Pruritic, eczematous lesions.</td> <td> </td> <td>UVA</td> <td> <p>In systemic photoallergy, MED for UVA decreased, UVB and visible light MEDs normal.</p> Occasional drugs have reduced MED to UVB rather than UVA.</td> <td> </td> <td>Resolves with discontinuation of inciting agent</td> <td>Usually due to topical agents</td> </tr> <tr> <td><strong>Erythropoietic protoporphyria</strong></td> <td>M = F, versus slight M&gt;F</td> <td>Onset in early childhood</td> <td>Symptoms begin within minutes of sun exposure, improves in winter</td> <td>Nose, cheeks, hands</td> <td>Burning and stinging, pain, pruritus. Erythema, edema, purpura. Heals with atrophic, wax-like scars; wrinkled knuckles.</td> <td>Common (siblings), autosomal recessive or pseudodominant</td> <td>Soret band (400 to 410 nm)</td> <td>Often normal, some patients may note stinging sensation or lesions</td> <td>Elevated erythrocyte protoporphyrin level</td> <td>Chronic</td> <td>May develop liver disease</td> </tr> <tr class="highlight_lght_gray_text"> <td><strong>Porphyria cutanea tarda</strong></td> <td>M = F</td> <td>Middle age, may occur earlier</td> <td> </td> <td>Sun-exposed areas</td> <td>Skin fragility, bullae, crusts, scarring. Hypertrichosis, hyperpigmentation, sclerodermoid changes.</td> <td>Sporadic in type I, autosomal dominant in type II</td> <td>Soret band (400 to 410 nm)</td> <td> </td> <td>Elevated porphyrins in urine and stool</td> <td>Chronic, symptoms improve with sun protection, removal of triggers, phlebotomy, antimalarials</td> <td>Often associated with hepatitis C</td> </tr> <tr> <td><strong>Pseudoporphyria</strong></td> <td>F&gt;M</td> <td>Any age; 10% of children taking naproxen</td> <td> </td> <td>Sun-exposed areas</td> <td>Skin fragility, bullae, crusts, scarring, milia.</td> <td>Negative</td> <td>UVA</td> <td> </td> <td>Normal porphyrin levels</td> <td>Symptoms resolve with sun protection, avoidance of tanning bed use, and discontinuation of the causative medications</td> <td>May be caused by medications, renal failure and hemodialysis, and excessive tanning bed use</td> </tr> </tbody></table></div><div class="graphic_footnotes">F: female; M: male; UVA: ultraviolet A; UVB: ultraviolet B; MED: minimal erythema dose; MUD: minimal urticarial dose.</div><div id="graphicVersion">Graphic 57800 Version 14.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
